Arrowpoint Investment Partners’s Novo Nordisk NVO Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-8,600	Closed	-$597K	–	283
2025 Q1	$597K	Buy	8,600 +6,393	+290%	+$444K	0.07%	68
2024 Q4	$190K	Buy	+2,207	New	+$190K	0.04%	104